Working on my annual #biopharma and #medtech “Winners & Losers” presentation for the Genesis 2024 conference. Happy to receive nominations for entry into the list - list them here or send to Michael.Ward@clarivate.com
Just to let my followers here know, like many others, I will be transitioning to Blue Sky - my handle will be @BioPharmaMike.bsky.social #biotech#biopharma#medtech
First #USFDA NDA submission for any psychedelic-assisted therapy as MAPS PBC seeks approval for an #MDMA-assisted therapy for #PTSD; #NDA includes two Phase 3 trials (MAPP1 and MAPP2) that both met primary and secondary endpoints #pharma#biotech
The 2023 #Nobel Prize in Physiology or Medicine has been awarded to Katalin Kariko and Drew Weissman, the scientists that developed the technology that led to the #mRNA#Covid vaccines. #biotech#pharma
Excited to share, this year’s @Clarivate Drugs to Watch report is the winner ow.ly/8Xg550PIXIA of TWO 2023 #DataComms Awards -- GOLD in the Best Data Insight from an Integrated Campaign category and BRONZE in the Most Innovative Use of Data category!
Pleased to take part in latest episode of the #BioWorld Insider Podcast, alongside BioWorld managing editor Karen Carey to talk about #biopharma deal making, M&A and financing trends in 1H 2023 plus how U.K. firms faring post #Brexit Download from here: lnkd.in/gMGeJHdT
The @WHO global research agenda for antimicrobial resistance #AMR in human health prioritizes 40 R&D topics to generate new evidence to inform AMR policies and interventions by 2030. Available here: lnkd.in/ej9tNbXh. #WHO#AMRResearchAgenda#Launch
Coming up on June 15, a webinar hosted by @BioPharmaMike of @Clarivate will feature ACMA CEO William Soliman, Ph.D., for a conversation on the impact of biologics and biosimilars on the US Market.
Register here: hubs.ly/Q01SvnBT0
Life science research has accelerated over the past few decades, especially with challenge of #COVID. @Clarivate experts Jonathan Adams and David Pendlebury from the #ISI discuss how scientific #research is evolving in the US. Listen at ow.ly/ECJc50OAUxX.
#pharma#biotech
Looking forward to what looks like a very cool event in London on 21st June - the World Without Disease Summit - stellar speaker line up worldwithoutdisease.com/
Since 2017, Mainland China has greatly expanded availability of novel drugs through regulatory reforms, bringing greater access from domestic and international manufacturers alike. Read our latest blog here: ow.ly/QbsT50OtujO#oncology#rarediseases#pharma#MainlandChina